Michael John Sumner serves as Executive at INOVIO PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Michael John Sumner has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 30, 2025 involved exercising options for 2,916 shares valued at $0.
Michael John Sumner currently holds 17,850 shares of INOVIO PHARMACEUTICALS, INC. (INO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael John Sumner has been a net neutral trader of INO stock. They have purchased $0 and sold $0 worth of shares.
Michael John Sumner's most recent insider trade was on Jun 30, 2025, when they sold 2,916 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 30, 2023 | INO | $0 | Option Exercise | 35,000 | $N/A | Discretionary |